Showing results (271-280 of 324) with videos related to

Sort By:
Pageof 33
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy SpecimensMingxuan Xu, Coya Tapia, Joud Hajjar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2018
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A ExpressionLu Huang, Shruti Malu, Jodi A McKenzie, et al.
The New England Journal of Medicine|June 3, 2011
gp100 peptide vaccine and interleukin-2 in patients with advanced melanomaDouglas J Schwartzentruber, David H Lawson, Jon M Richards, et al.
Nature Communications|September 8, 2017
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genesRina M Mbofung, Jodi A McKenzie, Shruti Malu, et al.
PNAS Nexus|August 25, 2022
Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I moleculesKyle R Jackson, Dinler A Antunes, Amjad H Talukder, et al.
Nature Cell Biology|February 17, 2015
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasisEinav Shoshan, Aaron K Mobley, Russell R Braeuer, et al.
The New England Journal of Medicine|June 5, 2012
Safety and activity of anti-PD-L1 antibody in patients with advanced cancerJulie R Brahmer, Scott S Tykodi, Laura Q M Chow, et al.
Oncoimmunology|July 7, 2017
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot studyYong Qin, Mariana Petaccia de Macedo, Alexandre Reuben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2022
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic MelanomaCaitlin A Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, et al.
The Journal of Clinical Investigation|May 13, 2022
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockadeAmber Hickman, Joost Koetsier, Trevin Kurtanich, et al.
Pageof 33